NASDAQ: AKYA
Akoya Biosciences Inc Stock Ownership - Who owns Akoya Biosciences?

Insider buying vs selling

Have Akoya Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John Frederick EkCFO2025-04-0116,432$1.35
$22.18kSell
Niro Phd RamachandranChief Business Officer2025-03-232,310$1.70
$3.93kSell
Brian McKelligonPresident and CEO2025-03-237,550$1.70
$12.84kSell
Jennifer KamocsayChief Legal Officer2025-03-013,851$1.63
$6.28kSell
Jennifer KamocsayChief Legal Officer2025-03-013,594$1.63
$5.86kSell
Pascal BamfordChief Clinical Officer2025-03-011,283$1.63
$2.09kSell
Pascal BamfordChief Clinical Officer2025-03-012,567$1.63
$4.18kSell
John Frederick EkCFO2025-03-013,594$1.63
$5.86kSell
Brian McKelligonPresident and CEO2025-03-017,550$1.63
$12.31kSell
Brian McKelligonPresident and CEO2025-03-018,257$1.63
$13.46kSell

1 of 2

AKYA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKYA insiders and whales buy or sell their stock.

AKYA Shareholders

What type of owners hold Akoya Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Thomas A. Raffin33.33%16,601,311$18.26MInsider
Thomas P. Schnettler11.15%5,556,492$6.11MInsider
Blue Water Life Science Advisors LP9.43%4,697,785$5.17MInstitution
Blackrock Inc3.29%1,637,330$1.80MInstitution
Vanguard Group Inc2.82%1,407,062$1.55MInstitution
Matthew Winkler1.98%984,513$1.08MInsider
Paragon Associates Paragon Associates II Joint Venture1.61%801,000$881.10kInstitution
Robert G. Shepler1.55%774,184$851.60kInsider
Geode Capital Management LLC1.14%565,489$622.04kInstitution
Garry Phd Nolan1.11%555,084$610.59kInsider

1 of 3

AKYA vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKYA24.36%52.80%Net SellingNet Selling
MBOT3.18%91.62%
MLSS5.66%57.05%Net Buying
FEMY8.61%6.55%
POCI11.43%88.57%Net BuyingNet Buying

Akoya Biosciences Stock Ownership FAQ

Who owns Akoya Biosciences?

Akoya Biosciences (NASDAQ: AKYA) is owned by 24.36% institutional shareholders, 52.80% Akoya Biosciences insiders, and 22.84% retail investors. Thomas A. Raffin is the largest individual Akoya Biosciences shareholder, owning 16.60M shares representing 33.33% of the company. Thomas A. Raffin's Akoya Biosciences shares are currently valued at $19.42M.

If you're new to stock investing, here's how to buy Akoya Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.